NCT06023940

Variability in Microbial Response to Dietary Fiber

University of Missouri-Columbia·ClinicalTrials.gov·dietary supplementRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
High fiber
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
University of Missouri-Columbia
Location
Columbia, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 12, 2022
End date
Apr 30, 2024
Enrollment
80 participants
Primary outcome

Variability in microbial composition as measured by 'alpha diversity',Concentration of SCFA

Summary

The goal of this clinical trial is to understand varying in responses to different dietary
 patterns in healthy people who are getting a health screening colonoscopy.
 
 The main questions it aims to answer are:
 
 - What is the variability in the change of the microbes in the gut of (1) a provided diet
 that is high in fiber vs (2) a diet of the participant's choice.
 
 - What is the magnitude of fasting changes in glucose and lipids following the short-term,
 high-fiber feeding period and identify candidate predictive factors (short-chain fatty
 acids, BMI, sex, starting glucose level) for these changes
 
 Participants will be in one of two groups:
 
 1. High-fiber diet group: These participants will have a series of measurements that
 include: blood biochemistries, body composition measured via DEXA, anthropometrics,
 surveys and questionnaires, and collection of fecal samples.
 
 2. Normal diet group: These participants will eat a diet that is of their choosing (ad
 libitum) and will have a series of measurements that include: fecal samples, and
 questionnaires/surveys including food records.

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06023940
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06023940 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Missouri-Columbia and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.